Absorption: As α-tocopherol, variable. Stored in fatty tissues. Metabolization: Tocophersolan is hydrolysed in the intestine. α-tocopherol is glucuronidated in the liver. Elimination: largely via the bile (75%), with the faeces.
No information is present at this moment.
No information is present at this moment.
| Chronic cholestasis |
|---|
|
| Supplementation in cystic fibrosis |
|---|
|
GFR ≥10 ml/min/1.73m2: Dose adjustment not required.
GFR <10 ml/min/1.73m2: A general recommendation on dose adjustment cannot be provided.
The complete list of all undesirable drug reactions can be found in the national Summary of Product Characteristics (SmPC) – click here
No information is present at this moment.
The complete list of all contra-indications can be found in the national Summary of Product Characteristics (SmPC) – click here
Vedrop must not be used in premature infants.
The complete list of all warnings and precautions can be found in the national Summary of Product Characteristics (SmPC) – click here
No information available on specific warnings and precautions in children.
The complete list of all interactions can be found in the national Summary of Product Characteristics (SmPC) – click here
This pages provides a list of drugs from the same ATC class for comparison. This does not necessarily mean that these drugs are interchangeable.
| Other plain vitamin preparations | ||
|---|---|---|
| A11HA05 | ||
| A11HA01 | ||
| A11HA06 | ||
| A11HA02 | ||
| A11HA04 | ||
| A11HA03 | ||